All In MedTech

Device Trial Radar · NCT07215546

Enhanced Sternal Closure With Montage or Montage-CT to Evaluate Post-Operative Opioid Use Following Median Sternotomy

Last checked: Nov 20, 2026Latest source record: Oct 10, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Enrolling by invitation

Status

Enrolling by invitation

Enrollment

150

Planned (sponsor's estimate)

Start

Oct 2025

Primary completion

Dec 2025

Study completion Apr 2026

Sponsor

Lead sponsor
Abyrx, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Oct 10, 2025

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 19 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a retrospective study based on analysis real world data obtained from hospitals that have adopted use of Montage or Montage-CT for use following sternotomy. The analysis will report the post-operative use of analgesic medication (including opioids) and compare the use against a control group consisting of patients operated by the same surgeon concurrently or prior to adoption of Montage or Montage-CT for use in sternotomy closure.

Conditions

  • Retrospective Review
  • Cerclage
  • Pain Management

Interventions

  • Montage or Montage CTDevice

    Application of Montage or Montage-CT Settable Resorbable Bone Putty to the cut sternal edge at the time of closure.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Cumulative Opiod DoseTime frame: From admission until end of treatment/discharge, up to 8 weeks

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • NCH Rooney Heart Institute

    Naples, Florida

  • Washington University

    St Louis, Missouri

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.